New investment of the pharmaceutical sector in the State of Mexico

The company Neolpharma will invest in the State of Mexico and will expand its plants in Ecatepec and Toluca; In addition, it will build a Distribution Center and a Vial Plant by 2024.

The Mexican governor, Alfredo Del Mazo, reported that this new project will have an approximate investment of 123 million dollars, and that among its purposes the acquisition of new technology for the Toluca plant and the expansion of warehouses and facilities at the plant stand out. from Ecatepec.

In his meeting with directors of this company, the state president explained that the expansion of this company will create about 1,470 jobs, while strengthening its production lines in state territory, as well as its distribution capacity in the center of the country.

The state leader also recognized Neolpharma for promoting quality of life among its employees, for its commitment to environmental sustainability, and for promoting families through corporate social responsibility programs.

Neolpharma

It stands out for being a company with 45 years of experience in the production and development of pharmaceutical products of the highest quality, and over the years it has maintained a research and development policy with which it has registered 250 products in medical branches such as neurosciences, oncology, dermatology, gastroenterology, pulmonology and cardiovascular.

Its products use sustainable technologies and processes that increase its effectiveness for the benefit of its patients, consolidating itself as one of the most important national companies in the market with international projection and influence in Latin America. One of its main plants, in Puerto Rico, has an annual production capacity of more than 5 billion units.